Shell Asset Management Co. cut its stake in Express Scripts Holding Company (NASDAQ:ESRX) by 0.4% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 90,938 shares of the company’s stock after selling 358 shares during the period. Shell Asset Management Co.’s holdings in Express Scripts Holding were worth $5,805,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of ESRX. Professional Advisory Services Inc. boosted its position in Express Scripts Holding by 5.5% in the first quarter. Professional Advisory Services Inc. now owns 249,792 shares of the company’s stock valued at $16,464,000 after buying an additional 12,912 shares in the last quarter. Nisa Investment Advisors LLC boosted its position in Express Scripts Holding by 8.1% in the first quarter. Nisa Investment Advisors LLC now owns 273,440 shares of the company’s stock valued at $18,022,000 after buying an additional 20,440 shares in the last quarter. DnB Asset Management AS boosted its position in Express Scripts Holding by 7.1% in the first quarter. DnB Asset Management AS now owns 66,644 shares of the company’s stock valued at $4,393,000 after buying an additional 4,400 shares in the last quarter. Lodestar Investment Counsel LLC IL boosted its position in Express Scripts Holding by 2.8% in the first quarter. Lodestar Investment Counsel LLC IL now owns 10,947 shares of the company’s stock valued at $722,000 after buying an additional 300 shares in the last quarter. Finally, Asset Planning Services Ltd. boosted its position in Express Scripts Holding by 17.3% in the first quarter. Asset Planning Services Ltd. now owns 8,619 shares of the company’s stock valued at $568,000 after buying an additional 1,273 shares in the last quarter. Hedge funds and other institutional investors own 90.24% of the company’s stock.

Shares of Express Scripts Holding Company (NASDAQ ESRX) opened at 61.73 on Wednesday. The firm’s 50-day moving average price is $62.51 and its 200 day moving average price is $64.30. The company has a market cap of $35.65 billion, a price-to-earnings ratio of 10.71 and a beta of 0.90. Express Scripts Holding Company has a 12-month low of $57.80 and a 12-month high of $77.61.

Express Scripts Holding (NASDAQ:ESRX) last released its quarterly earnings data on Tuesday, July 25th. The company reported $1.73 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.71 by $0.02. The business had revenue of $25.35 billion during the quarter, compared to analyst estimates of $25.52 billion. Express Scripts Holding had a return on equity of 25.58% and a net margin of 3.50%. The company’s revenue was up .5% on a year-over-year basis. During the same quarter last year, the business posted $1.57 EPS. On average, analysts predict that Express Scripts Holding Company will post $6.99 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: This news story was published by Watch List News and is owned by of Watch List News. If you are viewing this news story on another website, it was illegally stolen and republished in violation of US & international copyright laws. The legal version of this news story can be accessed at https://www.watchlistnews.com/express-scripts-holding-company-esrx-stake-decreased-by-shell-asset-management-co/1492920.html.

Several research analysts have recently weighed in on the company. Bank of America Corporation restated a “neutral” rating and issued a $77.00 price target on shares of Express Scripts Holding in a research note on Tuesday, April 25th. Cowen and Company decreased their price target on Express Scripts Holding from $90.00 to $83.00 and set an “outperform” rating for the company in a research note on Tuesday, April 25th. SunTrust Banks, Inc. restated a “buy” rating on shares of Express Scripts Holding in a research note on Tuesday, April 25th. Mizuho decreased their price target on Express Scripts Holding from $76.00 to $61.00 and set a “neutral” rating for the company in a research note on Tuesday, April 25th. Finally, UBS AG set a $71.00 price target on Express Scripts Holding and gave the stock a “hold” rating in a research note on Tuesday, April 25th. Four investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $71.17.

In other Express Scripts Holding news, VP Phyllis S. Anderson sold 1,100 shares of Express Scripts Holding stock in a transaction dated Friday, May 19th. The stock was sold at an average price of $60.08, for a total transaction of $66,088.00. Following the completion of the transaction, the vice president now owns 11,108 shares in the company, valued at approximately $667,368.64. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.68% of the company’s stock.

Express Scripts Holding Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Company (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with Analyst Ratings Network's FREE daily email newsletter.